关注
Alexander Andrianov
Alexander Andrianov
Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, principal scientist
在 iboch.by 的电子邮件经过验证
标题
引用次数
引用次数
年份
Method of determining protein conformations by the two-dimensional nuclear overhauser en-hancement spectroscopy data
AA Sherman, S.A., Andrianov, A.M., Akhrem
Journal of Biomolecular Structure and Dynamics 4 (5), 869-884, 1987
621987
Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design
AM Andrianov, IV Anishchenko
Journal of Biomolecular Structure and Dynamics 27 (2), 179-193, 2009
502009
Immunophilins and HIV-1 V3 loop for structure-based anti-AIDS drug design
AM Andrianov
Journal of Biomolecular Structure and Dynamics 26 (4), 445-454, 2009
442009
Local structural properties of the V3 loop of Thailand HIV-1 isolate
AM Andrianov, V Ivanov
Journal of Biomolecular Structure and Dynamics 19 (6), 973-989, 2002
352002
Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120
AM Andrianov
Journal of Biomolecular Structure and Dynamics 16 (4), 931-953, 1999
341999
Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
AM Andrianov, YV Kornoushenko, AD Karpenko, IP Bosko, AV Tuzikov
Journal of Biomolecular Structure and Dynamics 39 (15), 5779-5791, 2021
312021
Discovery of novel promising targets for anti-AIDS drug developments by computer modeling: application to the HIV-1 gp120 V3 loop
AM Andrianov, IV Anishchenko, AV Tuzikov
Journal of chemical information and modeling 51 (10), 2760-2767, 2011
312011
Method of modeling protein structure by the two-dimensional nuclear magnetic resonance spectroscopy data; application to the proteinase inhibitor BUSI IIA from bull seminal plasma
AA Sherman, S. A., Andrianov, A. M, Akhrem
5 4, 785-801, 1988
30*1988
Structure and polymorphism of the principal neutralization site of Thailand HIV-1 isolate
AM Andrianov, YA Sokolov
Journal of Biomolecular Structure and Dynamics 20 (4), 603-613, 2003
282003
Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors
AM Andrianov, GI Nikolaev, NA Shuldov, IP Bosko, AI Anischenko, ...
Journal of Biomolecular Structure and Dynamics 40 (16), 7555-7573, 2022
272022
Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter
DO Sviridov, AM Andrianov, IV Anishchenko, JA Stonik, MJA Amar, ...
Journal of Pharmacology and Experimental Therapeutics 344 (1), 50-58, 2013
242013
Dual spatial folds and different local structures of the HIV-1 immunogenic crown in various virus isolates
AM Andrianov
Journal of Biomolecular Structure and Dynamics 22 (2), 159-170, 2004
242004
3D structure model of the principal neutralizing epitope of Minnesota HIV-1 isolate
AM Andrianov, YA Sokolov
Journal of Biomolecular Structure and Dynamics 21 (4), 577-590, 2004
242004
Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving
AM Andrianov
Expert Opinion on Drug Discovery 6 (4), 419-435, 2011
212011
Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein
AM Andrianov
Journal of Biomolecular Structure and Dynamics 26 (1), 49-56, 2008
192008
Promises of combined use of molecular mechanics and nuclear overhauser effect spectroscopy in modeling spatial peptide and protein structures
AM Andrianov, SA Sherman
Studia Biophysica 135 (2), 107-114, 1990
191990
Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe
AM Andrianov, YV Kornoushenko, IV Anishchenko, VF Eremin, ...
Journal of Biomolecular Structure and Dynamics 31 (7), 665-683, 2013
172013
Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches
AM Andrianov, VG Veresov
Biochemistry (Moscow) 71, 906-914, 2006
162006
Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates
AM Andrianov, VG Veresov
Journal of Biomolecular Structure and Dynamics 24 (6), 597-608, 2007
152007
Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01
AM Andrianov, IA Kashyn, AV Tuzikov
Journal of Molecular Graphics and Modelling 61, 262-271, 2015
132015
系统目前无法执行此操作,请稍后再试。
文章 1–20